Short answer
JOINT Corp (JYNT) filed its Q3 2025 10-Q quarterly report on Nov 7, 2025 for the quarter ended Sep 30, 2025. Quarterly revenue was $13M (down 55.7% year over year) with net income of $855,009.
Q3 2025 key financials · XBRL
- Revenue
- $13M
- −55.7% YoY · +0.8% QoQ
- Net income
- $855,009
- +127.0% YoY · +229.2% QoQ
- Operating margin
- 1.2%
- EPS (diluted)
- $0.05
- +123.8% YoY · +150.0% QoQ
Source: XBRL data from the JOINT Corp (JYNT) Q3 2025 10-Q on SEC EDGAR. USD.
JOINT Corp Q3 2025 10-Q analysis
AI summary of MD&A and risk factor updates
Management Discussion & Analysis
- Q3 revenue $13.4M, up 5.7% YoY from $12.7M, led by franchise fees up 38.3% to $965K
- Operating margin 1.2% vs (3.9)% YoY, based on operating income $161K versus loss of $493K
- System-wide sales $127.3M, down 1.5%; mature-clinic comp sales worst performer, down 4.9%
- Cash and short-term deposits $29.7M; operating cash flow used $1.1M through nine months
- Q3 stock repurchases $2.3M; labor costs, inflation, elevated interest rates, and macro volatility remained headwinds
Risk Factors
- No risk-factors section provided in the submitted 10-Q excerpt
- New $5.0 million stock-repurchase authorization through June 3, 2027
- Repurchase program fully exhausted by October 21, 2025
- September 30, 2025 credit-agreement amendment with JPMorgan Chase Bank
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other JOINT Corp quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.